The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 73.
697. lappuse
Howard I. Forman. ed compound , differences in biochemical properties were not to be considered . The court rejected this contention stating : " We see no reason to distinguish between chemical and bio- chemical properties and no reason ...
Howard I. Forman. ed compound , differences in biochemical properties were not to be considered . The court rejected this contention stating : " We see no reason to distinguish between chemical and bio- chemical properties and no reason ...
766. lappuse
... properties , or the magnetic properties , the working and form- ing properties , or other properties must indeed be critical to war- rant patent protection . The properties had in the alloy of interest must be such that they differ in ...
... properties , or the magnetic properties , the working and form- ing properties , or other properties must indeed be critical to war- rant patent protection . The properties had in the alloy of interest must be such that they differ in ...
791. lappuse
... properties could be readily shown . I believe that tests would reveal that the properties are different not merely in matters of corrosion resistance , but in other properties , for example , harden- ability . With that amount of ...
... properties could be readily shown . I believe that tests would reveal that the properties are different not merely in matters of corrosion resistance , but in other properties , for example , harden- ability . With that amount of ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention